Security key
729139105
PLIANT THERAPEUTICS, INC. - Common Stock, par value $0.0001 per share (PLRX)
CUSIP: 729139105
Q3 2021 13F Holders as of 30 Sep 2021
- Security type / class
- Equity / Common Stock, par value $0.0001 per share
- Total 13F shares
- 30,380,086
- Total 13F value
- $512,798,759
- Share change
- -296,005
- SEC-reported price per share
- $16.88
- Number of holders
- 75
- Value change
- -$14,863,235
- Number of buys
- 37
- Number of sells
- 29
- Shares outstanding
- 61,399,727
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q3 2021
Institutions
75
Top holders
10
PLRX full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q4 2021
Previous quarter: Q2 2021
PLIANT THERAPEUTICS, INC. SEC filings
PLIANT THERAPEUTICS, INC. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 729139105
Recent filing periods:
Ownership snapshot
Top reported holders of PLRX - PLIANT THERAPEUTICS, INC. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
TRV GP III, LLC
Disclosed value leader
TRV GP III, LLC
Comparable rows
15/15
Latest evidence
30 Jun 2021
13F
Lead comparable stake: 9.5%
Showing 1-6 of 15 holder rows.
Quick read
TRV GP III, LLC leads the comparable SEC ownership view at 9.5%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens TRV GP III, LLC's linked filing trail.
Comparable ownership
Top 5
TRV GP III, LLC
9.5%
FMR LLC
8.8%
Redmile Group, LLC
5.1%
EVENTIDE ASSET MANAGEMENT, LLC
4%
CHI Advisors LLC
3.9%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| TRV GP III, LLC |
13F
Company
|
9.5%
|
$170,036,000
5,839,160 shares
|
— | 30 Jun 2021 |
| FMR LLC |
13F
Company
|
8.8%
|
$156,787,000
5,384,168 shares
|
— | 30 Jun 2021 |
| Redmile Group, LLC |
13F
Company
|
5.1%
|
$91,914,000
3,156,401 shares
|
— | 30 Jun 2021 |
| EVENTIDE ASSET MANAGEMENT, LLC |
13F
Company
|
4%
|
$71,981,000
2,471,892 shares
|
— | 30 Jun 2021 |
| CHI Advisors LLC |
13F
Company
|
3.9%
|
$68,953,000
2,367,888 shares
|
— | 30 Jun 2021 |
| TRV GP IV, LLC |
13F
Company
|
3.5%
|
$62,109,000
2,132,867 shares
|
— | 30 Jun 2021 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2021
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
75
Shares
30,380,086
Rows available
75
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2021 vs Q2 2021 Across Filers
Q2 2021 holders
80
Q3 2021 holders
75
Holder diff
-5
| Investor | Q2 2021 Shares | Q3 2021 Shares | Share Diff | Share Chg % | Q2 2021 value | Q3 2021 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend